(GSK) Glaxosmithkline Plc complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Plc | (GSK) share price targets
Complete technical analysis of Glaxosmithkline Plc (GSK) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Plc (GSK)
Glaxosmithkline Plc trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-21 View latest technical analysis
10 day averaged volume of Glaxosmithkline Plc is 4577800
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Fri Nov 2025 | 47.19 | 46.49 | 47.32 | 46.47 | 0.925 times |
| 20 Thu Nov 2025 | 46.11 | 46.60 | 46.60 | 45.81 | 1.356 times |
| 19 Wed Nov 2025 | 46.34 | 47.02 | 47.08 | 46.32 | 1.357 times |
| 18 Tue Nov 2025 | 47.37 | 47.03 | 47.48 | 46.96 | 1.012 times |
| 17 Mon Nov 2025 | 47.53 | 47.60 | 47.98 | 47.42 | 0.816 times |
| 14 Fri Nov 2025 | 47.18 | 47.32 | 47.57 | 47.10 | 1.104 times |
| 13 Thu Nov 2025 | 48.14 | 48.02 | 48.69 | 48.01 | 0.882 times |
| 12 Wed Nov 2025 | 48.07 | 47.76 | 48.31 | 47.52 | 0.779 times |
| 11 Tue Nov 2025 | 48.41 | 47.83 | 48.48 | 47.82 | 0.855 times |
| 10 Mon Nov 2025 | 47.36 | 46.75 | 47.37 | 46.56 | 0.625 times |
My analysis of stock is bullish for shortterm, and stock might move up till 47.9 or till 49.3. Use a stoploss of 46.75 and if this stock hits its stoploss, then it can fall down till 45.57
Share price targets for Glaxosmithkline Plc (GSK)
| Target Type | Value |
| Downside Target | 35.45 |
| Downside Target | 36.75 |
| Downside Target | 38.63 |
| Downside Target | 40.11 |
| Downside Target | 42.85 |
| Downside Target | 45.81 |
| Downside Target | 47.12 |
| Downside Target | 47.16 |
| Upside Target | 47.21 |
| Upside Target | 47.98 |
| Upside Target | 48.69 |
Intraday share price targets for Glaxosmithkline Plc (GSK)
| Target Type | Value |
| Downside Intraday Target | 46.01 |
| Downside Intraday Target | 44.82 |
| Upside Intraday Target | 48.18 |
| Upside Intraday Target | 49.16 |
| Downside Intraday Target | 46.99 |
Weekly technical analysis of Glaxosmithkline Plc (GSK)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Fri Nov 2025 | 47.19 | 47.60 | 47.98 | 45.81 | 1.288 times |
| 14 Fri Nov 2025 | 47.18 | 46.75 | 48.69 | 46.56 | 1.072 times |
| 07 Fri Nov 2025 | 46.63 | 46.29 | 47.21 | 45.81 | 3.607 times |
| 31 Fri Oct 2025 | 46.86 | 46.85 | 47.12 | 46.57 | 0.121 times |
| 31 Fri Oct 2025 | 46.86 | 43.85 | 47.16 | 42.89 | 1.599 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Glaxosmithkline Plc (GSK)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Fri Nov 2025 | 47.19 | 46.29 | 48.69 | 45.81 | 0.449 times |
| 31 Fri Oct 2025 | 46.86 | 44.22 | 47.16 | 42.85 | 1.478 times |
| 30 Tue Sep 2025 | 43.16 | 39.16 | 43.32 | 38.63 | 1.399 times |
| 29 Fri Aug 2025 | 39.67 | 37.68 | 40.57 | 36.75 | 0.494 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Glaxosmithkline Plc (GSK)
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Glaxosmithkline Plc in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.24 and Glaxosmithkline Plc (GSK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc (GSK) stock. Volume based technical analysis of Glaxosmithkline Plc (GSK) stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Glaxosmithkline Plc in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.24 and Glaxosmithkline Plc (GSK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc (GSK) stock. Volume based technical analysis of Glaxosmithkline Plc (GSK) stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.